Agreed, assuming they can keep the same sales trajectory through the year without increasing costs, indeed their guidance is a slight decrease in costs. Lets assume they can get by with no R&D and lower costs, but yet increasing sales. You are still looking at a new capital raise in Q4 '19, which would obviously be dilutive to the current share price.
YOJ Price at posting:
8.1¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)